KATIE GRUBB: Open Payments
NPI 1962808048 · EAST BERNSTADT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 54 payments from 11 companies in 2025. Trend: 2023 $1,445 · 2024 $1,501 · 2025 $1,326
Food & beverage: $1,326
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $331 |
| AstraZeneca Pharmaceuticals LP | 8 | $324 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $194 |
| Lilly USA, LLC | 11 | $166 |
| Axsome Therapeutics, Inc. | 3 | $161 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: FARXIGA, Ozempic, Kerendia, Auvelity, Rybelsus, MOUNJARO, REXULTI, TEZSPIRE.
Industry payments across KY — which companies pay providers there.
